Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry
•The first report of Iranian National Population-based Cancer Registry was presented.•Our results showed that Iran is a medium-risk area for incidence of cancers.•The incidence rates of stomach and bladder cancers were specifically high in Iran.•The results suggested very low incidence rates of cerv...
Saved in:
Published in | Cancer epidemiology Vol. 61; pp. 50 - 58 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
01.08.2019
Elsevier Limited |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | •The first report of Iranian National Population-based Cancer Registry was presented.•Our results showed that Iran is a medium-risk area for incidence of cancers.•The incidence rates of stomach and bladder cancers were specifically high in Iran.•The results suggested very low incidence rates of cervix uteri cancer in Iran.•We found considerable geographical diversities in incidence rate of cancers in Iran.
We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.
Total population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.
Overall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.
Our results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran. |
---|---|
AbstractList | •The first report of Iranian National Population-based Cancer Registry was presented.•Our results showed that Iran is a medium-risk area for incidence of cancers.•The incidence rates of stomach and bladder cancers were specifically high in Iran.•The results suggested very low incidence rates of cervix uteri cancer in Iran.•We found considerable geographical diversities in incidence rate of cancers in Iran.
We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.
Total population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.
Overall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.
Our results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran. We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.BACKGROUNDWe aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.Total population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.METHODSTotal population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.Overall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.RESULTSOverall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.Our results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran.CONCLUSIONOur results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran. BackgroundWe aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.MethodsTotal population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels.ResultsOverall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran.ConclusionOur results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran. We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014. Total population of Iran in 2014 was 76,639,000. The INPCR covered 30 out of 31 provinces (98% of total population). It registered only cases diagnosed with malignant new primary tumors. The main sources for data collection included pathology center, hospitals as well as death registries. Quality assessment and analysis of data were performed by CanReg-5 software. Age standardized incidence rates (ASR) (per 100,000) were reported at national and subnational levels. Overall, 112,131 new cancer cases were registered in INPCR in 2014, of which 60,469 (53.9%) were male. The diagnosis of cancer was made by microscopic confirmation in 76,568 cases (68.28%). The ASRs of all cancers were 177.44 and 141.18 in male and female, respectively. Cancers of the stomach (ASR = 21.24), prostate (18.41) and colorectum (16.57) were the most common cancers in men and the top three cancers in women were malignancies of breast (34.53), colorectum (11.86) and stomach (9.44). The ASR of cervix uteri cancer in women was 1.78. Our findings suggested high incidence of cancers of the esophagus, stomach and lung in North/ North West of Iran. Our results showed that Iran is a medium-risk area for incidence of cancers. We found differences in the most common cancers in Iran comparing to those reported for the World. Our results also suggested geographical diversities in incidence rates of cancers in different subdivisions of Iran. |
Author | Behrooz, Mohamadreza Jalilvand, Ahmad Joola, Parvin Soleimani, Ali Danechin, Leila Hazar, Narjes Mohamadifar, Hosein Yaghoubi-ashrafi, Majid Sadjadi, Alireza Enferadi, Floria Kazemzadeh, Yasan Kooshki, Maryam Tahmasebi, Zeinab Soltany-hojatabad, Maryam Shahi, Mehraban Ostovar, Afshin Sharifi-moghadam, Farroq Janbabaei, Ghasem Ghanbari-Motlagh, Ali Bayat, Amir-Hossein Davanlou, Masoud Poornajaf, Azadeh Abadi, Hakimeh Tavangar, Seyed-Mohammad Niksiar, Sharareh Rahnama, Amir Roshandel, Gholamreza Vahedi, Siamak Partovipour, Elham Khoshaabi, Mostafa Salavati, Fereshteh Yadolahi, Sohrab Esshaghi, soodabeh Pirnejad, Habibollah Reisi, Alireza Izadi, Mohsen Pourshahi, Gita Zendehdel, Kazem Fateh, Mansooreh Shahdadi, Athar Jazayeri, Mehrdad Rashidpour, Bahman Malekpour-afshar, Reza Poustchi, Hossein Golpazir, Arash Hoseini-hoshyar, Hosein Motidost-komleh, Rita Rezaei, Khadijeh Cheraghi, Maria Zareiyan, Aliakbar Mohamadzadeh, Gholamhasan Sadeghi, Gholamreza Farahani, Mohsen Mohammadi, Gohar Jafarnia, Ali Farrokhzad, Solmaz Madani, Amineh Jahantigh, Ma |
Author_xml | – sequence: 1 givenname: Gholamreza surname: Roshandel fullname: Roshandel, Gholamreza organization: Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran – sequence: 2 givenname: Ali surname: Ghanbari-Motlagh fullname: Ghanbari-Motlagh, Ali organization: Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran – sequence: 3 givenname: Elham surname: Partovipour fullname: Partovipour, Elham organization: Iranian National Population-Based Cancer Registry Secretariat, Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran – sequence: 4 givenname: Fereshteh surname: Salavati fullname: Salavati, Fereshteh organization: Iranian National Population-Based Cancer Registry Secretariat, Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran – sequence: 5 givenname: Susan surname: Hasanpour-Heidari fullname: Hasanpour-Heidari, Susan organization: Golestan Research Center of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran – sequence: 6 givenname: Gohar surname: Mohammadi fullname: Mohammadi, Gohar organization: Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran – sequence: 7 givenname: Mostafa surname: Khoshaabi fullname: Khoshaabi, Mostafa organization: Iranian National Population-Based Cancer Registry Secretariat, Cancer Office, Deputy of Health, Ministry of Health, Tehran, Iran – sequence: 8 givenname: Alireza surname: Sadjadi fullname: Sadjadi, Alireza organization: Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran – sequence: 9 givenname: Masoud surname: Davanlou fullname: Davanlou, Masoud organization: Pathobiology Laboratory, Bahman Hospital, Tehran, Iran – sequence: 10 givenname: Seyed-Mohammad surname: Tavangar fullname: Tavangar, Seyed-Mohammad organization: Department of Pathology, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran – sequence: 11 givenname: Hakimeh surname: Abadi fullname: Abadi, Hakimeh organization: Busher Cancer Registry, Busher University of Medical Sciences, Busher, Iran – sequence: 12 givenname: Abasali surname: Asgari fullname: Asgari, Abasali organization: Shahrekord Cancer Registry, Shahrekord University of Medical Sciences, Shahrekord, Iran – sequence: 13 givenname: Mohamadreza surname: Behrooz fullname: Behrooz, Mohamadreza organization: Torbateheidarieh Cancer Registry, Torbateheidarieh University of Medical Sciences, Torbate-heidarieh, Iran – sequence: 14 givenname: Maria surname: Cheraghi fullname: Cheraghi, Maria organization: Cancer Research Center, Cancer Registry Section, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran – sequence: 15 givenname: Leila surname: Danechin fullname: Danechin, Leila organization: Behbahan Cancer Registry, Behbahan University of Medical Sciences, Behbahan, Iran – sequence: 16 givenname: Roya surname: Dolatkhah fullname: Dolatkhah, Roya organization: Hematology and Oncology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran – sequence: 17 givenname: Floria surname: Enferadi fullname: Enferadi, Floria organization: Khorasan-North Cancer Registry, Khorasan-North University of Medical Sciences, Bojnord, Iran – sequence: 18 givenname: soodabeh surname: Esshaghi fullname: Esshaghi, soodabeh organization: Birjand Cancer Registry, Birjand University of Medical Sciences, Birjand, Iran – sequence: 19 givenname: Mohsen surname: Farahani fullname: Farahani, Mohsen organization: Arak Cancer Registry, Arak University of Medical Sciences, Arak, Iran – sequence: 20 givenname: Solmaz surname: Farrokhzad fullname: Farrokhzad, Solmaz organization: Qazvin Cancer Registry, Qazvin University of Medical Sciences, Qazvin, Iran – sequence: 21 givenname: Mansooreh surname: Fateh fullname: Fateh, Mansooreh organization: Center for Health Related Social and Behavioral Sciences Research, Shahroud University of Medical Sciences, Shahroud, Iran – sequence: 22 givenname: Siamak surname: Vahedi fullname: Vahedi, Siamak organization: Social Determinants of Health Research Center, Research Institute for Health Development, Kurdistan University of Medical Sciences, Sanandaj, Iran – sequence: 23 givenname: Arash surname: Golpazir fullname: Golpazir, Arash organization: Kermanshah Cancer Registry, Kermanshah University of Medical Sciences, Kermanshah, Iran – sequence: 24 givenname: Mahdieh surname: Hasanzadeh fullname: Hasanzadeh, Mahdieh organization: Bam Cancer Registry, Bam University of Medical Sciences, Bam, Iran – sequence: 25 givenname: Narjes surname: Hazar fullname: Hazar, Narjes organization: Department of Community Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran – sequence: 26 givenname: Hosein surname: Hoseini-hoshyar fullname: Hoseini-hoshyar, Hosein organization: Sabzevar Cancer Registry, Sabzevar University of Medical Sciences, Sabzevar, Iran – sequence: 27 givenname: Mohsen surname: Izadi fullname: Izadi, Mohsen organization: Gerash Cancer Registry, Gerash University of Medical Sciences, Gerash, Iran – sequence: 28 givenname: Ali surname: Jafarnia fullname: Jafarnia, Ali organization: Babol Cancer Registry, Babol University of Medical Sciences, Babol, Iran – sequence: 29 givenname: Mahdi surname: Jahantigh fullname: Jahantigh, Mahdi organization: Zahedan Cancer Registry, Zahedan University of Medical Sciences, Zahedan, Iran – sequence: 30 givenname: Ahmad surname: Jalilvand fullname: Jalilvand, Ahmad organization: Zanjan Cancer Registry, Zanjan University of Medical Sciences, Zanjan, Iran – sequence: 31 givenname: Mehrdad surname: Jazayeri fullname: Jazayeri, Mehrdad organization: Kashan Cancer Registry, Kashan University of Medical Sciences, Kashan, Iran – sequence: 32 givenname: Parvin surname: Joola fullname: Joola, Parvin organization: Dezfool Cancer Registry, Dezfool University of Medical Sciences, Dezfool, Iran – sequence: 33 givenname: Yasan surname: Kazemzadeh fullname: Kazemzadeh, Yasan organization: Khomein Cancer Registry, Khomein University of Medical Sciences, Khomein, Iran – sequence: 34 givenname: Maryam surname: Khalednejad fullname: Khalednejad, Maryam organization: Alborz Cancer Registry, Alborz University of Medical Sciences, Alborz, Iran – sequence: 35 givenname: Maryam surname: Kooshki fullname: Kooshki, Maryam organization: Lorestan Cancer Registry, Lorestan University of Medical Sciences, Lorestan, Iran – sequence: 36 givenname: Amineh surname: Madani fullname: Madani, Amineh organization: Abadan Cancer Registry, Abadan University of Medical Sciences, Abadan, Iran – sequence: 37 givenname: Reza surname: Malekpour-afshar fullname: Malekpour-afshar, Reza organization: Kerman Cancer Registry, Kerman University of Medical Sciences, Kerman, Iran – sequence: 38 givenname: Amir-Hossein surname: Bayat fullname: Bayat, Amir-Hossein organization: Saveh Cancer Registry, Saveh University of Medical Sciences, Saveh, Iran – sequence: 39 givenname: Zeinab surname: Moinfar fullname: Moinfar, Zeinab organization: Tehran Cancer Registry, Tehran University of Medical Sciences, Tehran, Iran – sequence: 40 givenname: Hosein surname: Mohamadifar fullname: Mohamadifar, Hosein organization: Fasa Cancer Registry, Fasa University of Medical Sciences, Fasa, Iran – sequence: 41 givenname: Gholamhasan surname: Mohamadzadeh fullname: Mohamadzadeh, Gholamhasan organization: Zabol Cancer Registry, Zabol University of Medical Sciences, Zabol, Iran – sequence: 42 givenname: Rita surname: Motidost-komleh fullname: Motidost-komleh, Rita organization: Iran University Cancer Registry, Iran University of Medical Sciences, Tehran, Iran – sequence: 43 givenname: Mahboobeh surname: Narooei fullname: Narooei, Mahboobeh organization: Iranshahr Cancer Registry, Iranshahr University of Medical Sciences, Iranshahr, Iran – sequence: 44 givenname: Sharareh surname: Niksiar fullname: Niksiar, Sharareh organization: Hamedan Cancer Registry, Hamedan University of Medical Sciences, Hamedan, Iran – sequence: 45 givenname: Habibollah surname: Pirnejad fullname: Pirnejad, Habibollah organization: Urmia Cancer Registry, Urmia University of Medical Sciences, Urmia, Iran – sequence: 46 givenname: Azadeh surname: Poornajaf fullname: Poornajaf, Azadeh organization: Ilam Cancer Registry, Ilam University of Medical Sciences, Ilam, Iran – sequence: 47 givenname: Gita surname: Pourshahi fullname: Pourshahi, Gita organization: Torbatejam Cancer Registry, Torbatejam University of Medical Sciences, Torbatejam, Iran – sequence: 48 givenname: Amir surname: Rahnama fullname: Rahnama, Amir organization: Rafsanjan Cancer Registry, Rafsanjan University of Medical Sciences, Rafsanjan, Iran – sequence: 49 givenname: Bahman surname: Rashidpour fullname: Rashidpour, Bahman organization: Yasooj Cancer Registry, Yasooj University of Medical Sciences, Yasooj, Iran – sequence: 50 givenname: Zahra surname: Ravankhah fullname: Ravankhah, Zahra organization: Esfahan Cancer Registry, Esfahan University of Medical Sciences, Esfahan, Iran – sequence: 51 givenname: Khadijeh surname: Rezaei fullname: Rezaei, Khadijeh organization: Mashhad Cancer Registry, Mashhad University of Medical Sciences, Mashhad, Iran – sequence: 52 givenname: Abbas surname: Rezaeianzadeh fullname: Rezaeianzadeh, Abbas organization: Shiraz Cancer Registry, Shiraz University of Medical Sciences, Shiraz, Iran – sequence: 53 givenname: Gholamreza surname: Sadeghi fullname: Sadeghi, Gholamreza organization: Guilan Cancer Registry, Guilan University of Medical Sciences, Rasht, Iran – sequence: 54 givenname: Athar surname: Shahdadi fullname: Shahdadi, Athar organization: Jiroft Cancer Registry, Jiroft University of Medical Sciences, Jiroft, Iran – sequence: 55 givenname: Mehraban surname: Shahi fullname: Shahi, Mehraban organization: Hormozgan Cancer Registry, Hormozgan University of Medical Sciences, Hormozgan, Iran – sequence: 56 givenname: Zahra surname: Sharafi fullname: Sharafi, Zahra organization: Neishaboor Cancer Registry, Neishaboor University of Medical Sciences, Neishaboor, Iran – sequence: 57 givenname: Farroq surname: Sharifi-moghadam fullname: Sharifi-moghadam, Farroq organization: Gonabad Cancer Registry, Gonabad University of Medical Sciences, Gonabad, Iran – sequence: 58 givenname: Ali surname: Soleimani fullname: Soleimani, Ali organization: Maragheh Cancer Registry, Maragheh University of Medical Sciences, Maragheh, Iran – sequence: 59 givenname: Maryam surname: Soltany-hojatabad fullname: Soltany-hojatabad, Maryam organization: Esfarayen Cancer Registry, Esfarayen University of Medical Sciences, Esfarayen, Iran – sequence: 60 givenname: Zeinab surname: Tahmasebi fullname: Tahmasebi, Zeinab organization: Larestan Cancer Registry, Larestan University of Medical Sciences, Larestan, Iran – sequence: 61 givenname: Sohrab surname: Yadolahi fullname: Yadolahi, Sohrab organization: Semnan Cancer Registry, Semnan University of Medical Sciences, Semnan, Iran – sequence: 62 givenname: Majid surname: Yaghoubi-ashrafi fullname: Yaghoubi-ashrafi, Majid organization: Mazandaran Cancer Registry, Mazandaran University of Medical Sciences, Sari, Iran – sequence: 63 givenname: Hamed surname: Zandian fullname: Zandian, Hamed organization: Social Determinants of Health Research Center, Ardabil University of Medical Sciences, Ardebil, Iran – sequence: 64 givenname: Aliakbar surname: Zareiyan fullname: Zareiyan, Aliakbar organization: Jahrom Cancer Registry, Jahrom University of Medical Sciences, Jahrom, Iran – sequence: 65 givenname: Hossein surname: Poustchi fullname: Poustchi, Hossein organization: Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran – sequence: 66 givenname: Kazem surname: Zendehdel fullname: Zendehdel, Kazem organization: Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran – sequence: 67 givenname: Afshin surname: Ostovar fullname: Ostovar, Afshin organization: Osteoporosis Research center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran – sequence: 68 givenname: Ghasem surname: Janbabaei fullname: Janbabaei, Ghasem organization: Deputy Minister of Treatment, Ministry of Health, Tehran, Iran – sequence: 69 givenname: Alireza surname: Reisi fullname: Reisi, Alireza organization: Deputy Minister of Health, Ministry of Health, Tehran, Iran – sequence: 70 givenname: Reza surname: Malekzadeh fullname: Malekzadeh, Reza email: dr.reza.malekzadeh@gmail.com, malek@tums.ac.ir organization: Digestive Oncology Research Center, Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31132560$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc2LFDEQxYOsuB_6FwjS4MVL91alvxUPMuzqwqKy7IK3kE4qmjHTPZt0C_Pfm56Z3cNc5lQv1O8V5L1zdtIPPTH2FiFDwOpymSnZ0zrjgG0GZQbQvmBn2NR1Wjf5r5NnzfGUnYewBKgqxPIVO80Rc15WcMa6hewV-cT2ymqKMqrkxst-nvFy8TG5ozC5MSSDScY_tF3auP8uRzv00iU_h_Xkto-0k4F0sj95R79tGP3mNXtppAv0Zj8v2MP11f3iW3r74-vN4sttqoq8HVOjeSNl0ZRSGyRuFIEyvERd57LjyHVedEqaGlA1nBMUHVAjDTWt5BIN5hfsw-7u2g-PE4VRrGxQ5FxMaZiC4DzHpsQSIKLvD9DlMPn4mZmqoIAWq5l6t6embkVarL1dSb8RT-lFIN8Byg8heDLPCIKYOxJLse1IzB0JKEXsKLraA5ey4za_0Uvrjng_77wUg_xnyYug7Fybtp7UKPRgj_g_HfiVs71V0v2lzVH3f755wI4 |
CitedBy_id | crossref_primary_10_32394_pe_75_51 crossref_primary_10_1038_s41598_022_26349_x crossref_primary_10_52547_ibj_3857 crossref_primary_10_1016_j_humgen_2022_201120 crossref_primary_10_1002_cnr2_70118 crossref_primary_10_1186_s12889_024_19407_8 crossref_primary_10_1002_ijc_33289 crossref_primary_10_3390_ijerph16224460 crossref_primary_10_1016_j_envpol_2021_118411 crossref_primary_10_52547_pbp_4_1_5 crossref_primary_10_34172_mejdd_2024_365 crossref_primary_10_1002_ijc_33574 crossref_primary_10_1186_s12885_019_6008_3 crossref_primary_10_1155_2024_5592802 crossref_primary_10_1097_WON_0000000000000948 crossref_primary_10_5812_jjhs_144589 crossref_primary_10_1016_j_gaceta_2020_12_003 crossref_primary_10_1016_j_clbc_2022_07_009 crossref_primary_10_1016_j_plabm_2024_e00406 crossref_primary_10_1080_0284186X_2023_2276326 crossref_primary_10_34172_bshj_26 crossref_primary_10_34172_aim_2022_59 crossref_primary_10_1136_bmjopen_2021_060562 crossref_primary_10_1177_21501319231186923 crossref_primary_10_1002_cnr2_1930 crossref_primary_10_1016_j_explore_2022_11_006 crossref_primary_10_1186_s12905_022_01877_w crossref_primary_10_1186_s12905_020_00903_z crossref_primary_10_1007_s40200_025_01581_0 crossref_primary_10_4103_jehp_jehp_1415_20 crossref_primary_10_5812_ijcm_109801 crossref_primary_10_1007_s12029_023_00952_1 crossref_primary_10_5812_ijcm_137805 crossref_primary_10_34172_aim_31133 crossref_primary_10_1016_j_cpcardiol_2021_100958 crossref_primary_10_5812_ijcm_139947 crossref_primary_10_1186_s13014_023_02327_z crossref_primary_10_1186_s12889_023_15417_0 crossref_primary_10_52547_jccs_2_1_35 crossref_primary_10_1007_s00520_019_05281_3 crossref_primary_10_5812_ijcm_137009 crossref_primary_10_61186_ibj_3857 crossref_primary_10_1016_j_canep_2021_102089 crossref_primary_10_5812_ijcm_139026 crossref_primary_10_3389_fonc_2021_561376 crossref_primary_10_5812_ijcm_136310 crossref_primary_10_1016_j_gsd_2023_100982 crossref_primary_10_1155_2021_6676666 crossref_primary_10_1002_cnr2_1927 crossref_primary_10_5812_jjm_144500 crossref_primary_10_1038_s41598_025_87494_7 crossref_primary_10_1007_s11356_023_26572_7 crossref_primary_10_3390_ijerph18010141 crossref_primary_10_52547_johe_11_1_1 crossref_primary_10_1155_2020_3534641 crossref_primary_10_5812_ijcm_109190 crossref_primary_10_1177_09691413211018253 crossref_primary_10_1016_j_ctarc_2022_100578 crossref_primary_10_1155_2020_1963814 crossref_primary_10_1093_ije_dyac031 crossref_primary_10_1186_s13104_020_05310_z crossref_primary_10_2174_0118749445268175231122051712 crossref_primary_10_30699_ijmm_14_1_43 crossref_primary_10_1371_journal_pone_0312707 crossref_primary_10_34172_aim_2020_28 crossref_primary_10_1002_hsr2_914 crossref_primary_10_1097_CEJ_0000000000000902 crossref_primary_10_1080_13813455_2020_1779311 crossref_primary_10_5812_ijcm_134832 crossref_primary_10_4103_ccij_ccij_170_20 crossref_primary_10_5812_jhealthscope_119827 crossref_primary_10_1186_s12912_021_00659_3 crossref_primary_10_1016_j_canep_2024_102685 crossref_primary_10_1038_s41598_023_34155_2 crossref_primary_10_1186_s12911_021_01609_4 crossref_primary_10_1186_s13027_021_00381_4 crossref_primary_10_4081_gh_2021_904 crossref_primary_10_61186_gebsj_12_2_216 crossref_primary_10_1002_cnr2_1973 crossref_primary_10_1186_s12885_023_11414_z crossref_primary_10_1016_j_canep_2020_101687 crossref_primary_10_1007_s10653_020_00562_x crossref_primary_10_1007_s40618_022_01751_4 crossref_primary_10_5812_ijcm_127005 crossref_primary_10_1016_j_nmni_2021_100865 crossref_primary_10_1186_s12885_024_11940_4 crossref_primary_10_1007_s40200_024_01416_4 crossref_primary_10_1016_j_cegh_2024_101537 crossref_primary_10_1007_s10708_023_10864_z crossref_primary_10_52547_ijhehp_10_1_17 crossref_primary_10_1186_s13063_024_08455_5 crossref_primary_10_4103_jehp_jehp_279_21 crossref_primary_10_5812_ijcm_135020 crossref_primary_10_1016_j_imu_2022_101011 crossref_primary_10_1007_s10654_020_00668_7 crossref_primary_10_3390_nu14122506 crossref_primary_10_1002_cnr2_1967 crossref_primary_10_2217_bmt_2021_0004 crossref_primary_10_1186_s12876_024_03520_4 crossref_primary_10_34172_aim_2023_01 crossref_primary_10_1186_s13104_024_06737_4 crossref_primary_10_29252_koomesh_23_1_56 crossref_primary_10_1016_j_gene_2023_147795 |
Cites_doi | 10.7314/APJCP.2015.16.2.451 10.1016/S0140-6736(18)32252-9 10.7314/APJCP.2015.16.17.7507 10.7314/APJCP.2016.17.2.733 10.7314/APJCP.2015.16.4.1409 10.1016/j.ajg.2013.11.002 10.1200/JCO.2005.05.2308 10.4103/0973-1482.172134 10.3322/caac.21218 10.1111/ecc.12754 10.1002/ijc.25516 10.1002/ijc.28018 10.1007/s12282-015-0638-3 10.1001/jamaoncol.2016.5688 10.1016/j.canep.2017.12.014 10.1016/j.canep.2011.05.018 10.1016/j.cdp.2005.11.002 10.1016/j.aogh.2014.09.012 10.1007/s10549-018-4947-z 10.3322/caac.21492 10.1093/annonc/mdn642 10.1158/0008-5472.CAN-15-0556 10.1002/ijc.11359 10.3322/caac.21262 |
ContentType | Journal Article |
Copyright | 2019 Elsevier Ltd Copyright © 2019 Elsevier Ltd. All rights reserved. 2019. Elsevier Ltd |
Copyright_xml | – notice: 2019 Elsevier Ltd – notice: Copyright © 2019 Elsevier Ltd. All rights reserved. – notice: 2019. Elsevier Ltd |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7TO 7X7 7XB 88C 88E 8AO 8C1 8FI 8FJ 8FK 8G5 ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 K9. KB0 M0S M0T M1P M2O MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1016/j.canep.2019.05.009 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Nursing & Allied Health Database Oncogenes and Growth Factors Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) Research Library (Alumni Edition) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student Research Library Prep AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Health & Medical Collection (Alumni Edition) Healthcare Administration Database Medical Database Research Library Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Pharma Collection ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Research Library ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest Central Basic ProQuest One Academic Eastern Edition ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Research Library Prep MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: Proquest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Public Health |
EISSN | 1877-783X |
EndPage | 58 |
ExternalDocumentID | 31132560 10_1016_j_canep_2019_05_009 S1877782119300505 |
Genre | Historical Article Journal Article |
GeographicLocations | Iran |
GeographicLocations_xml | – name: Iran |
GroupedDBID | --- --K --M .1- .FO .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5VS 6DK 6DL 7-5 71M 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8G5 8P~ AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AATTM AAXKI AAXUO AAYWO ABBQC ABFRF ABGSF ABJNI ABMAC ABMZM ABUDA ABUWG ABWVN ABXDB ACDAQ ACGFS ACIEU ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADUVX ADVLN AEBSH AEFWE AEHWI AEIPS AEKER AENEX AEUPX AEVXI AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGHFR AGUBO AGYEJ AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI AXJTR AZQEC BENPR BKEYQ BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU DU5 DWQXO EBS EFJIC EFKBS EJD EMOBN EP2 EP3 EX3 F5P FDB FIRID FNPLU FYGXN FYUFA GBLVA GNUQQ GUQSH HMCUK HZ~ J1W KOM M0T M1P M2O M41 MO0 N9A NAPCQ O-L O9- OAUVE OC~ OO- OZT P-8 P-9 PC. PHGZM PHGZT PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO Q38 ROL SDF SEL SES SPCBC SSH SSU SSZ SV3 T5K UKHRP UNMZH WOW Z5R ~G- 0SF 3V. AACTN AAIAV ABLVK ABYKQ AFKWA AJBFU AJOXV AMFUW DOVZS EFLBG LCYCR NCXOZ RIG AAYXX AGRNS ALIPV CITATION CGR CUY CVF ECM EIF NPM 7TO 7XB 8FK H94 K9. MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c439t-fd28aa485adf1e2fce0cf251d73ab212d34bcaf701c822e04b0e8afe89a2a1f13 |
IEDL.DBID | .~1 |
ISSN | 1877-7821 1877-783X |
IngestDate | Fri Jul 11 07:35:12 EDT 2025 Wed Aug 13 08:34:04 EDT 2025 Wed Feb 19 02:31:05 EST 2025 Thu Apr 24 23:09:00 EDT 2025 Tue Jul 01 03:50:35 EDT 2025 Fri Feb 23 02:19:40 EST 2024 Tue Aug 26 17:54:24 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Keywords | Registries Population surveillance Iran Cancer |
Language | English |
License | Copyright © 2019 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c439t-fd28aa485adf1e2fce0cf251d73ab212d34bcaf701c822e04b0e8afe89a2a1f13 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
PMID | 31132560 |
PQID | 2260409160 |
PQPubID | 1226362 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_2231851500 proquest_journals_2260409160 pubmed_primary_31132560 crossref_primary_10_1016_j_canep_2019_05_009 crossref_citationtrail_10_1016_j_canep_2019_05_009 elsevier_sciencedirect_doi_10_1016_j_canep_2019_05_009 elsevier_clinicalkey_doi_10_1016_j_canep_2019_05_009 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | August 2019 2019-08-00 20190801 |
PublicationDateYYYYMMDD | 2019-08-01 |
PublicationDate_xml | – month: 08 year: 2019 text: August 2019 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: New York |
PublicationTitle | Cancer epidemiology |
PublicationTitleAlternate | Cancer Epidemiol |
PublicationYear | 2019 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Semnani, Sadjadi, Fahimi, Nouraie, Naeimi, Kabir, Fakheri, Saadatnia, Ghavamnasiri, Malekzadeh (bib0085) 2006; 30 Forman, Bray, Brewster, Gombe Mbalawa, Kohler, Piñeros, Steliarova-Foucher, Swaminathan, Ferlay (bib0090) 2014; Vol. X Fritz, Percy, Jack, Shanmugaratnam, Sobin, Parkin, Whelan (bib0145) 2013 Roshandel, Boreiri, Sadjadi, Malekzadeh (bib0230) 2014; 80 Lee, Kim, Yu, Lee, Kim, Woo, Lee, Kim, Moon, Ko, Nam (bib0210) 2019; 173 Statistical Center of Iran (bib0120) 2011 Zendehdel, Mohebbi, Malekzadeh (bib0075) 2018; 27 Shakeri, Malekzadeh, Etemadi, Nasrollahzadeh, Aghcheli, Sotoudeh, Islami, Pourshams, Pawlita, Boffetta, Dawsey, Abnet, Kamangar (bib0185) 2013; 133 Ghasemi-Kebria, Ghaemi, Azadfar, Roshandel (bib0195) 2013; 14 Ervik, Cooke, Ferlay, Rahimi, Antomi, Dhivar, Carballo, Carranza (bib0150) 2008 Rafiemanesh, Lotfi, Bakhtazad, Ghoncheh, Salehiniya (bib0260) 2018; 14 Ferlay, Ervik, Lam, Colombet, Mery, Piñeros, Znaor, Soerjomataram, Bray (bib0025) 2018 Sadjadi, Malekzadeh, Derakhshan, Sepehr, Nouraie, Sotoudeh, Yazdanbod, Shokoohi, Mashayekhi, Arshi, Majidpour, Babaei, Mosavi, Mohagheghi, Alimohammadian (bib0080) 2003; 107 Fitzmaurice, Allen, Barber, Barregard, Bhutta, Brenner, Dicker, Chimed-Orchir, Dandona, Dandona, Fleming, Forouzanfar, Hancock, Hay, Hunter-Merrill, Huynh, Hosgood, Johnson, Jonas, Khubchandani, Kumar, Kutz, Lan, Larson, Liang, Lim, Lopez, MacIntyre, Marczak, Marquez, Mokdad, Pinho, Pourmalek, Salomon, Sanabria, Sandar, Sartorius, Schwartz, Shackelford, Shibuya, Stanaway, Steiner, Sun, Takahashi, Vollset, Vos, Wagner, Wang, Westerman, Zeeb, Zoeckler, Abd-Allah, Ahmed, Alabed, Alam, Aldhahri, Alem, Alemayohu, Ali, Al-Raddadi, Amare, Amoako, Artaman, Asayesh, Atnafu, Awasthi, Saleem, Barac, Bedi, Bensenor, Berhane, Bernabe, Betsu, Binagwaho, Boneya, Campos-Nonato, Castaneda-Orjuela, Catala-Lopez, Chiang, Chibueze, Chitheer, Choi, Cowie, Damtew, das Neves, Dey, Dharmaratne, Dhillon, Ding, Driscoll, Ekwueme, Endries, Farvid, Farzadfar, Fernandes, Fischer, TT, Gebru, Gopalani, Hailu, Horino, Horita, Husseini, Huybrechts, Inoue, Islami, Jakovljevic, James, Javanbakht, Jee, Kasaeian, Kedir, Khader, Khang, Kim, Leigh, Linn, Lunevicius, El Razek, Malekzadeh, Malta, Marcenes, Markos, Melaku, Meles, Mendoza, Mengiste, Meretoja, Miller, Mohammad, Mohammadi, Mohammed, Moradi-Lakeh, Nagel, Nand, Le Nguyen, Nolte, Ogbo, Oladimeji, Oren, Pa, Park, Pereira, Plass, Qorbani, Radfar, Rafay, Rahman, Rana, Soreide, Satpathy, Sawhney, Sepanlou, Shaikh, She, Shiue, Shore, Shrime, So, Soneji, Stathopoulou, Stroumpoulis, Sufiyan, Sykes, Tabares-Seisdedos, Tadese, Tedla, Tessema, Thakur, Tran, Ukwaja, Uzochukwu, Vlassov, Weiderpass, Wubshet Terefe, Yebyo, Yimam, Yonemoto, Younis, Yu, Zaidi, Zaki, Zenebe, Murray, Naghavi (bib0005) 2017; 3 Jensen (bib0135) 1991 Ferlay, Shin, Bray, Forman, Mathers, Parkin (bib0110) 2010; 127 Djalalinia, Modirian, Sheidaei, Yoosefi, Zokaiee, Damirchilu, Mahmoudi, Mahmoudi, Hajipour, Peykari, Rezaei, Haghshenas, Mohammadi, Delavari, Gouya, Naderimagham, Kousha, Moghisi, Mahdavihezaveh, Abachizadeh, Majdzadeh, Sayyari, Malekzadeh, Larijani, Farzadfar (bib0255) 2017; 20 Sadjadi, Nouraie, Mohagheghi, Mousavi-Jarrahi, Malekezadeh, Parkin (bib0035) 2005; 6 Ahmed, Asaduzzaman, Bashar, Hossain, Bhuiyan (bib0225) 2015; 16 Forman, Bray, Brewster, Gombe Mbalawa, Kohler, Piñeros, Steliarova-Foucher, Swaminathan, Ferlay (bib0160) 2013; Vol X Veisy, Lotfinejad, Salehi, Zhian (bib0215) 2015; 16 Curado (bib0130) 2008 Abdi, Latifi-Navid, Yazdanbod, Zahri (bib0175) 2016; 17 Masoompour, Yarmohammadi, Rezaianzadeh, Lankarani (bib0105) 2011; 35 Multiple primary rules working group (bib0140) 2004 Stevens, Brainard, Blask, Lockley, Motta (bib0205) 2014; 64 Somi, Farhang, Mirinezhad, Naghashi, Seif-Farshad, Golzari (bib0095) 2008; 9 Ferlay, Soerjomataram, Ervik, Dikshit, Eser, Mathers, Rebelo, Parkin, Forman, Bray (bib0115) 2013 Roshandel, Semnani, Malekzadeh, Dawsey (bib0250) 2012; 15 Bray, Colombet, Mery, Piñeros, Znaor, Zanetti, Ferlay (bib0165) 2017; Vol. XI (electronic version Ghasemi Kebria, Bagheri, Semnani, Ghaemi (bib0200) 2011; 2 Shakeri, Malekzadeh, Nasrollahzadeh, Pawlita, Murphy, Islami, Sotoudeh, Michel, Etemadi, Waterboer, Poustchi, Brennan, Boffetta, Dawsey, Kamangar, Abnet (bib0190) 2015; 75 Keyghobadi, Rafiemanesh, Mohammadian-Hafshejani, Enayatrad, Salehiniya (bib0100) 2015; 16 Gathirua-Mwangi, Zollinger, Murage, Pradhan, Champion (bib0220) 2015; 22 Roshandel, Sadjadi, Aarabi, Keshtkar, Sedaghat, Nouraie, Semnani, Malekzadeh (bib0050) 2012; 15 Rouhollahi, Mohagheghi, Mohammadrezai, Ghiasvand, Ghanbari Motlagh, Harirchi, Zendehdel (bib0055) 2014; 17 Statistical Center of Iran (bib0125) 2015 Etemadi, Sadjadi, Semnani, Nouraie, Khademi, Bahadori (bib0065) 2008; 11 Yusefi, Bagheri Lankarani, Bastani, Radinmanesh, Kavosi (bib0180) 2018; 19 Mohebbi, Nahvijou, Hadji, Rashidian, Seyyedsalehi, Nemati, Rouhollahi, Zendehdel (bib0170) 2017; 9 Bray, Ferlay, Soerjomataram, Siegel, Torre, Jemal (bib0015) 2018; 68 Habibi (bib0060) 1985; 70 Roshandel, Semnani, Fazel, Honarvar, Taziki, Sedaghat, Abdolahi, Ashaari, Poorabbasi, Hasanpour, Hosseini, Mansuri, Jahangirrad, Besharat, Moghaddami, Mirkarimi, Salamat, Ghasemi-Kebria, Jafari, Shokoohifar, Gholami, Sadjadi, Poustchi, Bray, Malekzadeh (bib0045) 2018; 52 L. The (bib0020) 2018; 392 Segi (bib0155) 1960 Mousavi, Gouya, Ramazani, Davanlou, Hajsadeghi, Seddighi (bib0040) 2009; 20 Kamangar, Dores, Anderson (bib0010) 2006; 24 Nemati, Rafei, Freedman, Fotouhi, Asgary, Zendehdel (bib0240) 2017; 20 Kamangar, Strickland, Pourshams, Malekzadeh, Boffetta, Roth, Abnet, Saadatian-Elahi, Rakhshani, Brennan, Etemadi, Dawsey (bib0245) 2005; 25 Torre, Bray, Siegel, Ferlay, Lortet-Tieulent, Jemal (bib0030) 2015; 65 Etemad, Guoya, Ramzani, Modirian, Partovipour, Salavati (bib0070) 2012 Zendehdel, Marzban, Nahvijou, Jafari (bib0235) 2012; 15 Fritz (10.1016/j.canep.2019.05.009_bib0145) 2013 Statistical Center of Iran (10.1016/j.canep.2019.05.009_bib0125) 2015 Ferlay (10.1016/j.canep.2019.05.009_bib0115) 2013 Multiple primary rules working group (10.1016/j.canep.2019.05.009_bib0140) 2004 Rouhollahi (10.1016/j.canep.2019.05.009_bib0055) 2014; 17 Lee (10.1016/j.canep.2019.05.009_bib0210) 2019; 173 Keyghobadi (10.1016/j.canep.2019.05.009_bib0100) 2015; 16 Forman (10.1016/j.canep.2019.05.009_bib0090) 2014; Vol. X Zendehdel (10.1016/j.canep.2019.05.009_bib0075) 2018; 27 Torre (10.1016/j.canep.2019.05.009_bib0030) 2015; 65 Ahmed (10.1016/j.canep.2019.05.009_bib0225) 2015; 16 Yusefi (10.1016/j.canep.2019.05.009_bib0180) 2018; 19 Bray (10.1016/j.canep.2019.05.009_bib0165) 2017; Vol. XI (electronic version Stevens (10.1016/j.canep.2019.05.009_bib0205) 2014; 64 Kamangar (10.1016/j.canep.2019.05.009_bib0010) 2006; 24 Sadjadi (10.1016/j.canep.2019.05.009_bib0035) 2005; 6 Curado (10.1016/j.canep.2019.05.009_bib0130) 2008 Gathirua-Mwangi (10.1016/j.canep.2019.05.009_bib0220) 2015; 22 Rafiemanesh (10.1016/j.canep.2019.05.009_bib0260) 2018; 14 Nemati (10.1016/j.canep.2019.05.009_bib0240) 2017; 20 Etemadi (10.1016/j.canep.2019.05.009_bib0065) 2008; 11 Ghasemi Kebria (10.1016/j.canep.2019.05.009_bib0200) 2011; 2 Mousavi (10.1016/j.canep.2019.05.009_bib0040) 2009; 20 Masoompour (10.1016/j.canep.2019.05.009_bib0105) 2011; 35 Somi (10.1016/j.canep.2019.05.009_bib0095) 2008; 9 Jensen (10.1016/j.canep.2019.05.009_bib0135) 1991 Shakeri (10.1016/j.canep.2019.05.009_bib0190) 2015; 75 Ferlay (10.1016/j.canep.2019.05.009_bib0025) 2018 Forman (10.1016/j.canep.2019.05.009_bib0160) 2013; Vol X Segi (10.1016/j.canep.2019.05.009_bib0155) 1960 Habibi (10.1016/j.canep.2019.05.009_bib0060) 1985; 70 Ferlay (10.1016/j.canep.2019.05.009_bib0110) 2010; 127 Kamangar (10.1016/j.canep.2019.05.009_bib0245) 2005; 25 Statistical Center of Iran (10.1016/j.canep.2019.05.009_bib0120) 2011 Sadjadi (10.1016/j.canep.2019.05.009_bib0080) 2003; 107 Ervik (10.1016/j.canep.2019.05.009_bib0150) 2008 Roshandel (10.1016/j.canep.2019.05.009_bib0230) 2014; 80 Bray (10.1016/j.canep.2019.05.009_bib0015) 2018; 68 Semnani (10.1016/j.canep.2019.05.009_bib0085) 2006; 30 Veisy (10.1016/j.canep.2019.05.009_bib0215) 2015; 16 Fitzmaurice (10.1016/j.canep.2019.05.009_bib0005) 2017; 3 L. The (10.1016/j.canep.2019.05.009_bib0020) 2018; 392 Roshandel (10.1016/j.canep.2019.05.009_bib0050) 2012; 15 Mohebbi (10.1016/j.canep.2019.05.009_bib0170) 2017; 9 Zendehdel (10.1016/j.canep.2019.05.009_bib0235) 2012; 15 Ghasemi-Kebria (10.1016/j.canep.2019.05.009_bib0195) 2013; 14 Roshandel (10.1016/j.canep.2019.05.009_bib0250) 2012; 15 Etemad (10.1016/j.canep.2019.05.009_bib0070) 2012 Djalalinia (10.1016/j.canep.2019.05.009_bib0255) 2017; 20 Abdi (10.1016/j.canep.2019.05.009_bib0175) 2016; 17 Shakeri (10.1016/j.canep.2019.05.009_bib0185) 2013; 133 Roshandel (10.1016/j.canep.2019.05.009_bib0045) 2018; 52 |
References_xml | – volume: 173 start-page: 189 year: 2019 end-page: 199 ident: bib0210 article-title: Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? publication-title: Breast Cancer Res. Treat. – volume: 35 start-page: e42 year: 2011 end-page: e47 ident: bib0105 article-title: Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry publication-title: Cancer Epidemiol. – year: 1960 ident: bib0155 article-title: Cancer Mortality for Selected Sites in 24 Countries (1950-57) – volume: 70 start-page: 105 year: 1985 end-page: 108 ident: bib0060 article-title: Epidemiological aspects of cancer in Iran publication-title: Int. Surg. – year: 2015 ident: bib0125 article-title: Report of Insurance Coverage in Iran – volume: 15 start-page: 196 year: 2012 end-page: 200 ident: bib0050 article-title: Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008 publication-title: Arch. Iran. Med. – volume: 11 start-page: 577 year: 2008 end-page: 580 ident: bib0065 article-title: Cancer registry in Iran: a brief overview publication-title: Arch. Iran. Med. – volume: 16 start-page: 7507 year: 2015 end-page: 7512 ident: bib0225 article-title: Association assessment among risk factors and breast cancer in a low income country: Bangladesh publication-title: Asian Pac. J. Cancer Prev. – volume: 20 start-page: 556 year: 2009 end-page: 563 ident: bib0040 article-title: Cancer incidence and mortality in Iran publication-title: Ann. Oncol. – volume: 14 start-page: 169 year: 2013 end-page: 172 ident: bib0195 article-title: Epidemiology of Helicobacter pylori infection among Iranian children publication-title: Arab J. Gastroenterol. – volume: 75 start-page: 4876 year: 2015 end-page: 4883 ident: bib0190 article-title: Multiplex H. Pylori serology and risk of gastric Cardia and Noncardia Adenocarcinomas publication-title: Cancer Res. – volume: Vol. XI (electronic version year: 2017 ident: bib0165 publication-title: Cancer Incidence in Five Continents – year: 2004 ident: bib0140 article-title: International Rules for Multiple Primary Cancers, Internal Report No 2004/02 – volume: 15 start-page: 713 year: 2012 end-page: 722 ident: bib0250 article-title: Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma publication-title: Arch. Iran. Med. – year: 2012 ident: bib0070 article-title: Annual Report of the National Cancer registry of Iran in 2009 – volume: 19 start-page: 591 year: 2018 end-page: 603 ident: bib0180 article-title: Risk factors for gastric cancer: a systematic review publication-title: Asian Pac. J. Cancer Prev. – volume: Vol. X year: 2014 ident: bib0090 article-title: Cancer incidence in five continents publication-title: IARC Scientific Publication No. 164 – volume: 3 start-page: 524 year: 2017 end-page: 548 ident: bib0005 article-title: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study publication-title: JAMA Oncol. – volume: 9 start-page: 3 year: 2017 end-page: 22 ident: bib0170 article-title: Iran Cancer statistics in 2012 and projection of Cancer incidence by 2035 publication-title: Basic Clin. Cancer Res. – volume: 15 start-page: 741 year: 2012 end-page: 746 ident: bib0235 article-title: Six-fold difference in the stomach cancer mortality rate between northern and southern Iran publication-title: Arch. Iran. Med. – year: 2008 ident: bib0130 article-title: Cancer Incidence in Five Continents-volume IX – volume: 64 start-page: 207 year: 2014 end-page: 218 ident: bib0205 article-title: Breast cancer and circadian disruption from electric lighting in the modern world publication-title: CA Cancer J. Clin. – volume: 107 start-page: 113 year: 2003 end-page: 118 ident: bib0080 article-title: Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran publication-title: Int. J. Cancer – volume: 20 start-page: 295 year: 2017 end-page: 301 ident: bib0240 article-title: Cigarette and water-pipe use in Iran: geographical distribution and time trends among the adult population; a pooled analysis of national STEPS surveys, 2006-2009 publication-title: Arch. Iran. Med. – volume: 6 start-page: 359 year: 2005 end-page: 363 ident: bib0035 article-title: Cancer occurrence in Iran in 2002, an international perspective publication-title: Asian Pac. J. Cancer Prev. – volume: Vol X year: 2013 ident: bib0160 article-title: Cancer incidence in five continents publication-title: IARC Scientific Publication No. 164 – volume: 127 start-page: 2893 year: 2010 end-page: 2917 ident: bib0110 article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 publication-title: Int. J. Cancer – volume: 80 start-page: 346 year: 2014 end-page: 357 ident: bib0230 article-title: A diversity of cancer incidence and mortality in West Asian populations publication-title: Ann. Glob. Health – volume: 392 start-page: 985 year: 2018 ident: bib0020 article-title: GLOBOCAN 2018: counting the toll of cancer publication-title: Lancet – volume: 17 start-page: 222 year: 2014 end-page: 231 ident: bib0055 article-title: Situation analysis of the National Comprehensive Cancer control Program (2013) in the I. R. Of Iran; assessment and recommendations based on the IAEA imPACT mission publication-title: Arch. Iran. Med. – year: 2013 ident: bib0145 article-title: International Classification of Diseases for Oncology (ICD-O) – volume: 20 start-page: 608 year: 2017 end-page: 616 ident: bib0255 article-title: Protocol design for large-scale cross-sectional studies of surveillance of risk factors of non-communicable diseases in Iran: STEPs 2016 publication-title: Arch. Iran. Med. – year: 2018 ident: bib0025 article-title: Global Cancer Observatory: Cancer Today – volume: 68 start-page: 394 year: 2018 end-page: 424 ident: bib0015 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. – volume: 30 start-page: 14 year: 2006 end-page: 19 ident: bib0085 article-title: Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance publication-title: Cancer Detect. Prev. – volume: 133 start-page: 455 year: 2013 end-page: 461 ident: bib0185 article-title: Opium: an emerging risk factor for gastric adenocarcinoma publication-title: Int. J. Cancer – year: 2011 ident: bib0120 article-title: Iranian National Census – volume: 16 start-page: 451 year: 2015 end-page: 455 ident: bib0215 article-title: Risk of breast cancer in relation to reproductive factors in North-West of Iran, 2013-2014 publication-title: Asian Pac. J. Cancer Prev. – volume: 16 start-page: 1409 year: 2015 end-page: 1413 ident: bib0100 article-title: Epidemiology and trend of cancers in the province of Kerman: southeast of Iran publication-title: Asian Pac. J. Cancer Prev. – year: 2008 ident: bib0150 article-title: CanReg5: Computer Software for Cancer Registries – volume: 27 year: 2018 ident: bib0075 article-title: Underestimation of cancer incidence in Iran and necessity for establishing population-based cancer registries publication-title: Eur. J. Cancer Care (Engl.) – year: 2013 ident: bib0115 article-title: GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 – volume: 14 start-page: 532 year: 2018 end-page: 536 ident: bib0260 article-title: The epidemiological and histological trend of bladder cancer in Iran publication-title: J. Cancer Res. Ther. – volume: 2 start-page: 256 year: 2011 end-page: 260 ident: bib0200 article-title: Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010) publication-title: Caspian J. Intern. Med. – volume: 22 start-page: 648 year: 2015 end-page: 656 ident: bib0220 article-title: Adult BMI change and risk of Breast Cancer: National Health and Nutrition Examination Survey (NHANES) 2005-2010 publication-title: Breast Cancer – volume: 9 start-page: 327 year: 2008 end-page: 330 ident: bib0095 article-title: Cancer in East Azerbaijan, Iran: results of a population-based cancer registry publication-title: Asian Pac. J. Cancer Prev. – volume: 17 start-page: 733 year: 2016 end-page: 738 ident: bib0175 article-title: Helicobacter pylori babA2 positivity predicts risk of gastric cancer in Ardabil, a very high-risk area in Iran publication-title: Asian Pac. J. Cancer Prev. – volume: 25 start-page: 425 year: 2005 end-page: 428 ident: bib0245 article-title: High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran publication-title: Anticancer Res. – volume: 52 start-page: 128 year: 2018 end-page: 133 ident: bib0045 article-title: Building cancer registries in a lower resource setting: the 10-year experience of Golestan, Northern Iran publication-title: Cancer Epidemiol. – volume: 65 start-page: 87 year: 2015 end-page: 108 ident: bib0030 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J. Clin. – volume: 24 start-page: 2137 year: 2006 end-page: 2150 ident: bib0010 article-title: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world publication-title: J. Clin. Oncol. – year: 1991 ident: bib0135 article-title: Cancer Registration: Principles and Methods – volume: 2 start-page: 256 issue: 3 year: 2011 ident: 10.1016/j.canep.2019.05.009_bib0200 article-title: Seroprevalence of anti-Hp and anti-cagA antibodies among healthy persons in Golestan province, northeast of Iran (2010) publication-title: Caspian J. Intern. Med. – volume: 16 start-page: 451 issue: 2 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0215 article-title: Risk of breast cancer in relation to reproductive factors in North-West of Iran, 2013-2014 publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2015.16.2.451 – volume: 11 start-page: 577 issue: 5 year: 2008 ident: 10.1016/j.canep.2019.05.009_bib0065 article-title: Cancer registry in Iran: a brief overview publication-title: Arch. Iran. Med. – volume: 392 start-page: 985 issue: 10152 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0020 article-title: GLOBOCAN 2018: counting the toll of cancer publication-title: Lancet doi: 10.1016/S0140-6736(18)32252-9 – volume: 17 start-page: 222 issue: 4 year: 2014 ident: 10.1016/j.canep.2019.05.009_bib0055 article-title: Situation analysis of the National Comprehensive Cancer control Program (2013) in the I. R. Of Iran; assessment and recommendations based on the IAEA imPACT mission publication-title: Arch. Iran. Med. – volume: 20 start-page: 608 issue: 9 year: 2017 ident: 10.1016/j.canep.2019.05.009_bib0255 article-title: Protocol design for large-scale cross-sectional studies of surveillance of risk factors of non-communicable diseases in Iran: STEPs 2016 publication-title: Arch. Iran. Med. – volume: 16 start-page: 7507 issue: 17 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0225 article-title: Association assessment among risk factors and breast cancer in a low income country: Bangladesh publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2015.16.17.7507 – volume: 17 start-page: 733 issue: 2 year: 2016 ident: 10.1016/j.canep.2019.05.009_bib0175 article-title: Helicobacter pylori babA2 positivity predicts risk of gastric cancer in Ardabil, a very high-risk area in Iran publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2016.17.2.733 – year: 1991 ident: 10.1016/j.canep.2019.05.009_bib0135 – volume: 16 start-page: 1409 issue: 4 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0100 article-title: Epidemiology and trend of cancers in the province of Kerman: southeast of Iran publication-title: Asian Pac. J. Cancer Prev. doi: 10.7314/APJCP.2015.16.4.1409 – volume: 14 start-page: 169 issue: 4 year: 2013 ident: 10.1016/j.canep.2019.05.009_bib0195 article-title: Epidemiology of Helicobacter pylori infection among Iranian children publication-title: Arab J. Gastroenterol. doi: 10.1016/j.ajg.2013.11.002 – volume: 24 start-page: 2137 issue: 14 year: 2006 ident: 10.1016/j.canep.2019.05.009_bib0010 article-title: Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2005.05.2308 – volume: 15 start-page: 196 issue: 4 year: 2012 ident: 10.1016/j.canep.2019.05.009_bib0050 article-title: Cancer incidence in Golestan Province: report of an ongoing population-based cancer registry in Iran between 2004 and 2008 publication-title: Arch. Iran. Med. – year: 2013 ident: 10.1016/j.canep.2019.05.009_bib0145 – volume: 14 start-page: 532 issue: 3 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0260 article-title: The epidemiological and histological trend of bladder cancer in Iran publication-title: J. Cancer Res. Ther. doi: 10.4103/0973-1482.172134 – volume: 64 start-page: 207 issue: 3 year: 2014 ident: 10.1016/j.canep.2019.05.009_bib0205 article-title: Breast cancer and circadian disruption from electric lighting in the modern world publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21218 – volume: 27 issue: 1 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0075 article-title: Underestimation of cancer incidence in Iran and necessity for establishing population-based cancer registries publication-title: Eur. J. Cancer Care (Engl.) doi: 10.1111/ecc.12754 – year: 2004 ident: 10.1016/j.canep.2019.05.009_bib0140 – volume: 127 start-page: 2893 issue: 12 year: 2010 ident: 10.1016/j.canep.2019.05.009_bib0110 article-title: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 publication-title: Int. J. Cancer doi: 10.1002/ijc.25516 – volume: 133 start-page: 455 issue: 2 year: 2013 ident: 10.1016/j.canep.2019.05.009_bib0185 article-title: Opium: an emerging risk factor for gastric adenocarcinoma publication-title: Int. J. Cancer doi: 10.1002/ijc.28018 – volume: 15 start-page: 741 issue: 12 year: 2012 ident: 10.1016/j.canep.2019.05.009_bib0235 article-title: Six-fold difference in the stomach cancer mortality rate between northern and southern Iran publication-title: Arch. Iran. Med. – volume: 22 start-page: 648 issue: 6 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0220 article-title: Adult BMI change and risk of Breast Cancer: National Health and Nutrition Examination Survey (NHANES) 2005-2010 publication-title: Breast Cancer doi: 10.1007/s12282-015-0638-3 – year: 2013 ident: 10.1016/j.canep.2019.05.009_bib0115 – volume: 3 start-page: 524 issue: 4 year: 2017 ident: 10.1016/j.canep.2019.05.009_bib0005 article-title: Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015: A Systematic Analysis for the Global Burden of Disease Study publication-title: JAMA Oncol. doi: 10.1001/jamaoncol.2016.5688 – volume: 52 start-page: 128 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0045 article-title: Building cancer registries in a lower resource setting: the 10-year experience of Golestan, Northern Iran publication-title: Cancer Epidemiol. doi: 10.1016/j.canep.2017.12.014 – year: 1960 ident: 10.1016/j.canep.2019.05.009_bib0155 – volume: 35 start-page: e42 issue: 5 year: 2011 ident: 10.1016/j.canep.2019.05.009_bib0105 article-title: Cancer incidence in southern Iran, 1998-2002: results of population-based cancer registry publication-title: Cancer Epidemiol. doi: 10.1016/j.canep.2011.05.018 – volume: 9 start-page: 327 issue: 2 year: 2008 ident: 10.1016/j.canep.2019.05.009_bib0095 article-title: Cancer in East Azerbaijan, Iran: results of a population-based cancer registry publication-title: Asian Pac. J. Cancer Prev. – volume: 15 start-page: 713 issue: 11 year: 2012 ident: 10.1016/j.canep.2019.05.009_bib0250 article-title: Polycyclic aromatic hydrocarbons and esophageal squamous cell carcinoma publication-title: Arch. Iran. Med. – volume: 30 start-page: 14 issue: 1 year: 2006 ident: 10.1016/j.canep.2019.05.009_bib0085 article-title: Declining incidence of esophageal cancer in the Turkmen Plain, eastern part of the Caspian Littoral of Iran: a retrospective cancer surveillance publication-title: Cancer Detect. Prev. doi: 10.1016/j.cdp.2005.11.002 – volume: 80 start-page: 346 issue: 5 year: 2014 ident: 10.1016/j.canep.2019.05.009_bib0230 article-title: A diversity of cancer incidence and mortality in West Asian populations publication-title: Ann. Glob. Health doi: 10.1016/j.aogh.2014.09.012 – volume: 20 start-page: 295 issue: 5 year: 2017 ident: 10.1016/j.canep.2019.05.009_bib0240 article-title: Cigarette and water-pipe use in Iran: geographical distribution and time trends among the adult population; a pooled analysis of national STEPS surveys, 2006-2009 publication-title: Arch. Iran. Med. – volume: 25 start-page: 425 issue: 1b year: 2005 ident: 10.1016/j.canep.2019.05.009_bib0245 article-title: High exposure to polycyclic aromatic hydrocarbons may contribute to high risk of esophageal cancer in northeastern Iran publication-title: Anticancer Res. – volume: 173 start-page: 189 issue: 1 year: 2019 ident: 10.1016/j.canep.2019.05.009_bib0210 article-title: Is the high proportion of young age at breast cancer onset a unique feature of Asian breast cancer? publication-title: Breast Cancer Res. Treat. doi: 10.1007/s10549-018-4947-z – volume: 68 start-page: 394 issue: 6 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0015 article-title: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21492 – volume: 20 start-page: 556 issue: 3 year: 2009 ident: 10.1016/j.canep.2019.05.009_bib0040 article-title: Cancer incidence and mortality in Iran publication-title: Ann. Oncol. doi: 10.1093/annonc/mdn642 – year: 2011 ident: 10.1016/j.canep.2019.05.009_bib0120 – volume: Vol X year: 2013 ident: 10.1016/j.canep.2019.05.009_bib0160 article-title: Cancer incidence in five continents – volume: 70 start-page: 105 issue: 2 year: 1985 ident: 10.1016/j.canep.2019.05.009_bib0060 article-title: Epidemiological aspects of cancer in Iran publication-title: Int. Surg. – volume: 75 start-page: 4876 issue: 22 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0190 article-title: Multiplex H. Pylori serology and risk of gastric Cardia and Noncardia Adenocarcinomas publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-0556 – year: 2008 ident: 10.1016/j.canep.2019.05.009_bib0130 – year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0125 – volume: 107 start-page: 113 issue: 1 year: 2003 ident: 10.1016/j.canep.2019.05.009_bib0080 article-title: Cancer occurrence in Ardabil: results of a population-based cancer registry from Iran publication-title: Int. J. Cancer doi: 10.1002/ijc.11359 – year: 2012 ident: 10.1016/j.canep.2019.05.009_bib0070 – volume: Vol. X year: 2014 ident: 10.1016/j.canep.2019.05.009_bib0090 article-title: Cancer incidence in five continents – volume: 9 start-page: 3 issue: 3 year: 2017 ident: 10.1016/j.canep.2019.05.009_bib0170 article-title: Iran Cancer statistics in 2012 and projection of Cancer incidence by 2035 publication-title: Basic Clin. Cancer Res. – year: 2008 ident: 10.1016/j.canep.2019.05.009_bib0150 – volume: Vol. XI (electronic version year: 2017 ident: 10.1016/j.canep.2019.05.009_bib0165 – volume: 19 start-page: 591 issue: 3 year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0180 article-title: Risk factors for gastric cancer: a systematic review publication-title: Asian Pac. J. Cancer Prev. – volume: 65 start-page: 87 issue: 2 year: 2015 ident: 10.1016/j.canep.2019.05.009_bib0030 article-title: Global cancer statistics, 2012 publication-title: CA Cancer J. Clin. doi: 10.3322/caac.21262 – volume: 6 start-page: 359 issue: 3 year: 2005 ident: 10.1016/j.canep.2019.05.009_bib0035 article-title: Cancer occurrence in Iran in 2002, an international perspective publication-title: Asian Pac. J. Cancer Prev. – year: 2018 ident: 10.1016/j.canep.2019.05.009_bib0025 |
SSID | ssj0066115 |
Score | 2.5578372 |
Snippet | •The first report of Iranian National Population-based Cancer Registry was presented.•Our results showed that Iran is a medium-risk area for incidence of... We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014. Total population of... BackgroundWe aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.MethodsTotal... We aimed to report, for the first time, the results of the Iranian National Population-based Cancer Registry (INPCR) for the year 2014.BACKGROUNDWe aimed to... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 50 |
SubjectTerms | Adolescent Adult Aged Aged, 80 and over Annual reports Bladder Breast Cancer Cervical cancer Child Child, Preschool Collaboration Colleges & universities Conflicts of interest Cooperation Data collection Epidemiology Esophagus Female Health risk assessment History, 21st Century Humans Incidence Infant Infant, Newborn Iran Iran - epidemiology Leukemia Male Middle Aged Mortality Neoplasms - epidemiology Nervous system Pathology Population Population surveillance Prostate Provinces Quality control Registries Registries - statistics & numerical data Stomach Thyroid gland Trends Tumors Young Adult |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3dSxwxEA_1CiKI-NV6ekoKfTR0s8nd5nyRIooKSjl6cG8hnwU57ux9_P_OZLPrS70-7UI-yO5MMr9MJvMj5LuMygVTeDaUooINSnRMSe5Z5OkgRgJiRn_H0_PgfiwfJ_1Jdrgtc1hlsyamhdrPHfrIfwBMAH0DMFNcv_5lyBqFp6uZQmOLfMbUZRjSVU3aDReYnsRgwFVVMbCEvMk6lOK7YOQBE1byYUrdiRGJ_7ZMHyHPZIHu9sleho70Zy3rA_IpzA7J9lM-HD8ku7ULjtY3i46IvUGJLih60xNzKLzRB7BN-IQRySs6Csv1dLWk80gBCKZCUBeak2VP6a-W3ouhufM0dzkKfxJL3DEZ393-vrlnmVKBOUAeKxZ9qYyRqm985KGMLhQuAsTxlTAWrJgX0joTq4I7QA6hkLYIysSghqY0PHLxhXRm81k4IdQGUbqqP_QKKdStVwC8hAX0yYXythRdUja_U7ucbxxpL6a6CSx70UkGGmWgi74GGXTJZdvotU63sbm6bOSkm5uksPZpMAebmw3aZhlo1ADi_w17jTLoPNeX-l0zu-RbWwyzFI9eoIf5GuvgLXUA31Dna61E7fcJzgUCz9PNnZ-RHRxJHXzYI53VYh3OARCt7EXS-jf6HgYW priority: 102 providerName: ProQuest |
Title | Cancer incidence in Iran in 2014: Results of the Iranian National Population-based Cancer Registry |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1877782119300505 https://dx.doi.org/10.1016/j.canep.2019.05.009 https://www.ncbi.nlm.nih.gov/pubmed/31132560 https://www.proquest.com/docview/2260409160 https://www.proquest.com/docview/2231851500 |
Volume | 61 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dSxtBEF9EQQSRatXGRtlCH3vm9naT2_hmgxJbDJJWyNuyn5ISEjHJq3-7M3t7B4VWwZf7nD32bmZnfrc7H4R8FUFar3OX9QUv4Qcl2EwK5rLA4kKMAMSM8x23o97wXvyYdCcbZFDHwqBbZdL9lU6P2jpd6aSv2XmcTju_GKayk5ihjMd6bBjBLkqU8vPnxs0DzE-sYoDEGVLXmYeijxf03mPSStaP6TvRK_Hf1ul_6DNaoesPZC_BR3pZ9XCfbPj5Adm-TQvkB2S3moajVXTRR2IGyNUnijPqsXooHNEbsE-4hx6JCzr2y_VstaSLQAEMxpsgMjQlzJ7Ru6bEV4Ymz9H0yLF_iJXiDsn99dXvwTBLZRUyC-hjlQVXSK2F7GoXmC-C9bkNAHNcybUBS-a4MFaHMmcW0IPPhcm91MHLvi40C4wfkc35Yu4_EWo8L2zZ7TuJZdSNkwC-uAEEyrh0puAtUtSfU9mUcxxLX8xU7Vz2R0UeKOSByrsKeNAi35pGj1XKjdfJRc0nVUeTgv5TYBJeb9Zrmv0lcG83bNfCoNJ4XyoAsaANAWrnLfKluQ0jFZdf4AmLNdJgpDoAcKA5roSoeT_OGEfwefLeXn0mO3hWuSa2yebqae1PAS6tzFkcD7AtJyVs5QCOty5vfg5HsP9-NbobvwDQMRRO |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB_qFVQoovXrtGoEfXNxs8l1cwURrS13tneUo4W-xWw-BDnu2t4d4j_l39iZ7GZ90fOpT7uwSchmJvP7JZnMALyRQVlvcpf1pShxgRJspiR3WeDxIEYiY6b9jtF4d3Amv573zjfgd7oLQ26VySZGQ-3mlvbI3yNNQH1DMpN_vLjMKGsUna6mFBq1Whz5Xz9xybb4MPyC8n1bFIcHp_uDrMkqkFkE32UWXKGMkapnXOC-CNbnNiDKu1KYCg25E7KyJpQ5twiePpdV7pUJXvVNYXjgAtu9BZtS4FKmA5ufD8Ynk2T7EexizgSuyjJD7OUpzlH0KMOx8hQik_djsFDygfw7Fv6L60bMO7wP9xqyyj7V2vUANvxsG26PmuP4bdiqN_1YfZfpIVT7pENXjPbvY65SfGNDREN6Yo_kHpv4xWq6XLB5YEg940dUUNaE556ykzahWEYA61jT5MR_j3npHsHZjQz3Y-jM5jP_FFjlRWHLXt8pStpeOYVUT1TId7lQripEF4o0nNo2Ec4p0cZUJ1e2HzrKQJMMdN7TKIMuvGsrXdQBPtYXl0lOOt1dRWurEYDWV9ttqzXUpqYs_6-4k5RBN9Zlof_MhS68bj-jXaDDHmxhvqIydC8e6T6WeVIrUft_gnNBVPfZ-sZfwZ3B6ehYHw_HR8_hLvWqdn3cgc7yauVfIB1bVi-bOcDg201Pu2t9VUZ1 |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3daxQxEB9qhSKIaNV6WjWCvhm62WS7OUFEWo-etaUUC_cWN1-CHHe1d4f4r_nXOZPdrC96PvXpDjYJu5mP3y_JZAbgpYrahabwfKhkjQuU6LhWwvMo0kGMQsZM-x0np_tHF-rjpJpswK98F4bCKrNPTI7azx3tke8hTUB9QzJT7MUuLOLscPTu8junClJ00prLabQqchx-_sDl2-Lt-BBl_aosRx8-HxzxrsIAdwjESx59qZtG6arxUYQyulC4iIjva9lYdOpeKuuaWBfCIZCGQtki6CYGPWzKRkQhcdwbcLOWlSAbqyf9Yg9hL1VPELquOaKwyBmPUmwZzlqgZJlimNKGUjTk31HxX6w3od_oLtzpaCt73-rZPdgIs23YOukO5rfhdrv9x9pbTffBHpA2XTHayU9VS_EfGyMu0i--kXrDzsNiNV0u2DwyJKHpIaoq6xJ1T9lZX1qME9R61g15Hr6mCnUP4OJaJvshbM7ms_AImA2ydHU19JrKt1uvkfRJi8xXSO1tKQdQ5uk0rst1TiU3piYHtX0zSQaGZGCKyqAMBvC673TZpvpY31xlOZl8ixX9rkEoWt9tv-_WkZyWvPy_425WBtP5mYX5YxUDeNE_Rg9Bxz44wnxFbeiGPBJ_bLPTKlH_fVIISaT38frBn8MWGpv5ND49fgK36KXaGMhd2FxercJT5GVL-ywZAIMv121xvwEdn0lF |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Cancer+incidence+in+Iran+in+2014%3A+Results+of+the+Iranian+National+Population-based+Cancer+Registry&rft.jtitle=Cancer+epidemiology&rft.au=Roshandel%2C+Gholamreza&rft.au=Ghanbari-Motlagh%2C+Ali&rft.au=Partovipour%2C+Elham&rft.au=Salavati%2C+Fereshteh&rft.date=2019-08-01&rft.pub=Elsevier+Ltd&rft.issn=1877-7821&rft.eissn=1877-783X&rft.volume=61&rft.spage=50&rft.epage=58&rft_id=info:doi/10.1016%2Fj.canep.2019.05.009&rft.externalDocID=S1877782119300505 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1877-7821&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1877-7821&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1877-7821&client=summon |